Ingevity (NYSE: NGVT) reported Q3 EPS of $1.64, $0.13 better than the analyst estimate of $1.51. Revenue for the quarter came in at $376.8 million versus the consensus estimate of $354.06 million.

GUIDANCE:

Ingevity sees FY2021 revenue of $1.32-1.36 billion, versus the consensus of $1.35 billion.

For earnings history and earnings-related data on Ingevity (NGVT) click here.